2
 Purpose/Objective(s) A combined X-ray contrast and optical imaging p rovides physiological and functional details of normal or diseased tis sue non-invasively at a molecular l evel. Through real time visualization, image acquisitions, delineating the tumor boundaries, the integration of op tical molecular imaging into the radiation tr eatment allows effective us e of radiation in radiation oncology. The design, construction, and validation of Molecular Image Guided Radiation Therapy (MIGRT) instrumentation for preclinical theragnostics will be described. Materials/Methods The multimodal molecular imaging module with appropriate shielding is e ngineered into a steel lined x-ray irradiator chamber. The MI module includes a s tage to immobilize and  position small animals (mice to rabbit) or tissue culture plates. Phosphor screens between the animal chamber and the detector facilitate both the optical and radiographic images to be captured at the same focal plane. A cooled charge-coupled device (CCD) based system images the specimen in X-ray mode and optical mode to allow co-registration of luminescent tumors or target tissues on an X-ray background of the animal or other samples. RT is achieved using x-ray tube with a homogenic beam powered by 320 kV stable X-ray generators using fixed and/or adjustable collimators. Oral Presentation By Dr. Rao Papineni  Development of Integrated Multimodal Molecular Imaging and X-ray Irradiator Module for Molecular Image Guided Radiation Therapy - MIGRT in Preclinical Research 

ASTRO 2014 MIGRT: Molecular IGRT- Dr. Rao Papineni

Embed Size (px)

DESCRIPTION

Presentation at ASTRO 2014American Society for Radiation Oncology, ASTRO's Annual Meeting is the premier radiation oncology scientific event in the world and draws more than 11,000 attendees each year. During the 2014 Annual Meeting, we will highlight science that showcases how technology and biology advance the field and improve patient outcomes and quality of life.

Citation preview

  • Purpose/Objective(s)

    A combined X-ray contrast and optical imaging provides physiological and functional details of

    normal or diseased tissue non-invasively at a molecular level. Through real time visualization,

    image acquisitions, delineating the tumor boundaries, the integration of optical molecular

    imaging into the radiation treatment allows effective use of radiation in radiation oncology. The

    design, construction, and validation of Molecular Image Guided Radiation Therapy (MIGRT)

    instrumentation for preclinical theragnostics will be described.

    Materials/Methods

    The multimodal molecular imaging module with appropriate shielding is engineered into

    a steel lined x-ray irradiator chamber. The MI module includes a stage to immobilize and

    position small animals (mice to rabbit) or tissue culture plates. Phosphor screens between the

    animal chamber and the detector facilitate both the optical and radiographic images to be

    captured at the same focal plane. A cooled charge-coupled device (CCD) based system images the specimen in X-ray mode and optical mode to allow co-registration of luminescent tumors or target

    tissues on an X-ray background of the animal or other samples. RT is achieved using x-ray tube

    with a homogenic beam powered by 320 kV stable X-ray generators using fixed and/or

    adjustable collimators.

    Oral Presentation By

    Dr. Rao Papineni

    Development of Integrated Multimodal Molecular Imaging and X-ray Irradiator Module for Molecular Image Guided Radiation Therapy - MIGRT in Preclinical Research

  • Results

    The design and fabrication of the integrated MIGRT, its validation, and the performance are

    completed. The radiation treatment protocol (whole body) followed by functional molecular

    imaging of the reactive oxygen species (ROS) response were performed on swiss albino mice.

    Significant changes in the luminescence signals a response to the changes in ROS activity were

    acquired real time without moving the animal or other specimen between imaging modalities or radiation treatment.

    Conclusions

    Efficient integration of the X-ray irradiation system capable to perform both optical and X-ray imaging of their cells, tissues or animals for pre-treatment MIGRT localization of target tissues and

    for post treatment diagnostics of results at a molecular and functional level is accomplished.

    Functional and molecular imaging during or post RT also opens novel opportunities to determine

    and explore the molecular mechanisms in radiation biology- thereby developing new therapeutic

    strategies complementing radiation therapy- with a distinct footprint in immunotherapy, adoptive

    cell therapy, and targeted chemotherapy.

    PI: Dr. Rao V. L. Papineni - [email protected]

    Coauthors: William McLaughlin, Brian Dermott, Douglas Vizard, and Juan C Gonzales. PACT & Health LLC

    Precision X-ray Inc

    & KUMC USA.

    American Society for Radiation Oncology, ASTRO's Annual Meeting is the premier radiation

    oncology scientific event in the world and draws more than 11,000 attendees each year. During

    the 2014 Annual Meeting, we will highlight science that showcases how technology and biology

    advance the field and improve patient outcomes and quality of life.